Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs
Muhammad Shahzeb Khan(University of Mississippi Medical Center), Erin D. Michos(Johns Hopkins University), Javed Butler(Jackson Memorial Hospital), Safi U. Khan(West Virginia University), Izza Shahid(Houston Methodist), Tariq Jamal Siddiqi(Dow University of Health Sciences), Haider J. Warraich(Advanced Research Projects Agency - Energy), Stephen J. Greene(Duke Medical Center)
Cited by 152
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
The Global Health and Economic Burden of Hospitalizations for Heart Failure
|Journal of the American College of Cardiology|2014|2k